A double-blind comparative trial of mianserin and maprotiline in the treatment of depression

Reference

• Balestrieri A., Benassi P., Cassano G. B., Catriogiovanni P., Catalano A., Colombi A., Conforto C., Del Soldat G., Giberti F., Lucchelli P. E., Muratoria A., Nistri M., Sarteschi P. Clinical comparative evaluation of maprotiline, a new antidepressant drug. A multicentre study. Int. Pharmacopsychiatry 1971; 6: 2361. Balestrieri A., Benassi P., Cassano G. B., Catriogiovanni P., Catalano A., Colombi A., Conforto C., Del Soldat G., Giberti F., Lucchelli P. E., Muratoria A., Nistri M., Sarteschi P. Clinical comparative evaluation of maprotiline, a new antidepressant drug. A multicentre study. Int. Pharmacopsychiatry 1971; 6: 236
   PubMedGoogle Scholar
• Beck A. T., Ward C. H., Mendelson M., Mock J., Erbaugh I. An inventory for measuring depression. Arch. Gen. Psychiatr. 1961; 4: 5612. Beck A. T., Ward C. H., Mendelson M., Mock J., Erbaugh I. An inventory for measuring depression. Arch. Gen. Psychiatr. 1961; 4: 561
   PubMed Web of Science ®Google Scholar
• Braithwaite R. A., Nakro B. R. S., Gaind R. Steady-state plasma concentrations during single and multiple dosage schedules of amitriptyline. Psychol. Med. 1974; 4: 3383. Braithwaite R. A., Nakro B. R. S., Gaind R. Steady-state plasma concentrations during single and multiple dosage schedules of amitriptyline. Psychol. Med. 1974; 4: 338
   PubMed Web of Science ®Google Scholar
• Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Mianserin. A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 1978; 16: 2734. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Mianserin. A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 1978; 16: 273
   PubMed Web of Science ®Google Scholar
• Crawford R., Donald A., Forrest A., Hay J. A clinical trial of maprotiline (Ludiomil) in the treatment of depressive patients in general practice and the psychiatric clinic. J. Int. Med. Res. 1975; 3: 89, Suppl. 25. Crawford R., Donald A., Forrest A., Hay J. A clinical trial of maprotiline (Ludiomil) in the treatment of depressive patients in general practice and the psychiatric clinic. J. Int. Med. Res. 1975; 3: 89, Suppl. 2
   Web of Science ®Google Scholar
• Crome P., Braithwaite R., Newman B., Montgomery S. Choosing an antidepressant. Br. Med. J. 1978; 1: 8596. Crome P., Braithwaite R., Newman B., Montgomery S. Choosing an antidepressant. Br. Med. J. 1978; 1: 859
   PubMed Web of Science ®Google Scholar
• Ghose K., Coppen A. J., Turner P. Autonomic actions and interactions of mianserin hydrochloride (Org GB94) and amitriptyline in patients with depressive illness. Psychopharmacology 1976; 49: 2017. Ghose K., Coppen A. J., Turner P. Autonomic actions and interactions of mianserin hydrochloride (Org GB94) and amitriptyline in patients with depressive illness. Psychopharmacology 1976; 49: 201
   PubMed Web of Science ®Google Scholar
• Guy W. Clinical Global Impressions. ECDEU Assessment Manual for Psycho-pharmacology. National Institute of Mental Health, Rockville, Md 1976; 2188. Guy W. Clinical Global Impressions. ECDEU Assessment Manual for Psycho-pharmacology. National Institute of Mental Health, RockvilleMd 1976; 218
   Google Scholar
• Hamer A. W. F., Vohra J. K., Sloman J. G., Burrows G. D., Davies B. M. Mianserin and intracardiac conduction. I.R.C.S. (Med. Sci.) 1979; 7: 2209. Hamer A. W. F., Vohra J. K., Sloman J. G., Burrows G. D., Davies B. M. Mianserin and intracardiac conduction. I.R.C.S. (Med. Sci.) 1979; 7: 220
   Google Scholar
• Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 5610. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56
   PubMed Web of Science ®Google Scholar
• Hattab J. R. The cardiovascular effects of Ludiomil in comparison with those of some tricyclic antidepressants. Paper presented at the Ludiomil Symposium. Malta 197611. Hattab J. R. The cardiovascular effects of Ludiomil in comparison with those of some tricyclic antidepressants. Paper presented at the Ludiomil Symposium. Malta 1976
   Google Scholar
• Jukes A. M. Maprotiline (Ludiomil): side-effects and overdosage. J. Int. Med. Res. 1975; 3: 126, Suppl. 212. Jukes A. M. Maprotiline (Ludiomil): side-effects and overdosage. J. Int. Med. Res. 1975; 3: 126, Suppl. 2
   Web of Science ®Google Scholar
• Kessell A., Holt N. F. A controlled study of a tetracyclic antidepressant -maprotiline (Ludiomil). Med. J. Aust. 1975; 1: 77313. Kessell A., Holt N. F. A controlled study of a tetracyclic antidepressant -maprotiline (Ludiomil). Med. J. Aust. 1975; 1: 773
   PubMed Web of Science ®Google Scholar
• Kopera H. Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo. Br. J. Clin. Pharmacol. 1978; 5: 29S–34S, Suppl. 114. Kopera H. Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo. Br. J. Clin. Pharmacol. 1978; 5: 29S–34S, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Montgomery S., McAuley R., Montgomery D. B. Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single night time and divided daily dose regimens. Br. J. Clin. Pharmacol. 1978; 5: 71S–76S, Suppl. 115. Montgomery S., McAuley R., Montgomery D. B. Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single night time and divided daily dose regimens. Br. J. Clin. Pharmacol. 1978; 5: 71S–76S, Suppl. 1
   Web of Science ®Google Scholar
• Murphy J. E. A comparison of a high and low dosage regimen of maprotiline (Ludiomil). Research and Clinical Investigation in Depression, J. E. Murphy. Cambridge Medical, Northampton 1976; 9516. Murphy J. E. A comparison of a high and low dosage regimen of maprotiline (Ludiomil). Research and Clinical Investigation in Depression, J. E. Murphy. Cambridge Medical, Northampton 1976; 95
   Google Scholar
• Paprocki J., Varvalho Neto E. Maprotiline. Short and long term therapy. Folha Med. 1974; 69: 35317. Paprocki J., Varvalho Neto E. Maprotiline. Short and long term therapy. Folha Med. 1974; 69: 353
   Google Scholar
• Peet M. Recent clinical and pharmacological studies of the novel antidepressant Org GB94. Drugs Exper. Clin. Res. 1977; 1: 36318. Peet M. Recent clinical and pharmacological studies of the novel antidepressant Org GB94. Drugs Exper. Clin. Res. 1977; 1: 363
   Google Scholar
• Pinder R. M., Brogden R. N., Speight T. M., Avery G. S. Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs 1977; 13: 32119. Pinder R. M., Brogden R. N., Speight T. M., Avery G. S. Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs 1977; 13: 321
   PubMed Web of Science ®Google Scholar
• Rehavi M., Maayani S., Sokolovsky M. Tricyclic antidepressants as antimuscarinic drugs. Biochem. Pharmacol. 1977; 26: 155920. Rehavi M., Maayani S., Sokolovsky M. Tricyclic antidepressants as antimuscarinic drugs. Biochem. Pharmacol. 1977; 26: 1559
   PubMed Web of Science ®Google Scholar
• Smith A. H. W., Naylor G. S., Moody J. P. Placebo controlled double-blind trial of mianserin hydrochloride. Br. J. Clin. Pharmacol. 1978; 5: 67S–70S, Suppl. 121. Smith A. H. W., Naylor G. S., Moody J. P. Placebo controlled double-blind trial of mianserin hydrochloride. Br. J. Clin. Pharmacol. 1978; 5: 67S–70S, Suppl. 1
   Google Scholar
• Vaisanen E., Ranta P., Nummikko-Pelkonen A., Tienari P. Mianserin hydrochloride (Org GB 94) in the treatment of obsessional states. J. Int. Med. Res. 1977; 5: 28922. Vaisanen E., Ranta P., Nummikko-Pelkonen A., Tienari P. Mianserin hydrochloride (Org GB 94) in the treatment of obsessional states. J. Int. Med. Res. 1977; 5: 289
   PubMed Web of Science ®Google Scholar
• Woggon B., Angst J., Gmuer M., Hess K., Hurwitz E., Martens H., Rothweiler R., Steiner A. Clinical double-blind study with two different dosages of maprotiline (150 or 225 mg per day). Arch. Psychiatr. Nervenkr. 1976; 222: 1323. Woggon B., Angst J., Gmuer M., Hess K., Hurwitz E., Martens H., Rothweiler R., Steiner A. Clinical double-blind study with two different dosages of maprotiline (150 or 225 mg per day). Arch. Psychiatr. Nervenkr. 1976; 222: 13
   PubMedGoogle Scholar
• Burkhardt R., Kienle G. Controlled clinical trials and medical ethics. Lancet 1978; 2: 135624. Burkhardt R., Kienle G. Controlled clinical trials and medical ethics. Lancet 1978; 2: 1356
   Web of Science ®Google Scholar
• Crome P., Braithwaite R., Newman B., Montgomery S. Choosing an antidepressant. Br. Med. J. 1978; 1: 85925. Crome P., Braithwaite R., Newman B., Montgomery S. Choosing an antidepressant. Br. Med. J. 1978; 1: 859
   PubMed Web of Science ®Google Scholar
• Editorial., Emotion and empiricism. Br. Med. J. 1979; 1: 28826. Editorial., Emotion and empiricism. Br. Med. J. 1979; 1: 288
   PubMed Web of Science ®Google Scholar
• Editorial., Controlled trials: planned deceptions?. Lancet 1979; 1: 53427. Editorial., Controlled trials: planned deceptions?. Lancet 1979; 1: 534
   PubMed Web of Science ®Google Scholar
• Freiman J. A., Chalmers T. C., Smith H., Jr., Kuebler R. R. The importance of beta, the Type II error and sample size in the design and interpretation of the randomized control trial. N. Engl. J. Med. 1978; 299: 69028. Freiman J. A., Chalmers T. C., Smith H., Jr., Kuebler R. R. The importance of beta, the Type II error and sample size in the design and interpretation of the randomized control trial. N. Engl. J. Med. 1978; 299: 690
   PubMed Web of Science ®Google Scholar
• Lasagna L. Placebo and controlled trials under attack. Eur. J. Clin. Pharmacol. 1979; 15: 37329. Lasagna L. Placebo and controlled trials under attack. Eur. J. Clin. Pharmacol. 1979; 15: 373
   PubMed Web of Science ®Google Scholar
• Morris J. F., Beck A. T. The efficacy of antidepressant drugs. Arch. Gen. Psychiatry 1974; 30: 66730. Morris J. F., Beck A. T. The efficacy of antidepressant drugs. Arch. Gen. Psychiatry 1974; 30: 667
   PubMed Web of Science ®Google Scholar
• Quitkin F., Rifkin A., Klein D. F. Monoamine oxidase inhibitors. A review of their antidepressant effectiveness. Arch. Gen. Psychiatry 1979; 36: 74931. Quitkin F., Rifkin A., Klein D. F. Monoamine oxidase inhibitors. A review of their antidepressant effectiveness. Arch. Gen. Psychiatry 1979; 36: 749
   PubMed Web of Science ®Google Scholar
• Rogers S. C., Clay P. M. A statistical review of controlled trials of imipramine and placebo in the treatment of depressive illness. Br. J. Psychiatry 1975; 127: 59932. Rogers S. C., Clay P. M. A statistical review of controlled trials of imipramine and placebo in the treatment of depressive illness. Br. J. Psychiatry 1975; 127: 599
   PubMed Web of Science ®Google Scholar